Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies
US9982046B2 · kind B2 · utility
2Cited by
12References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2016 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Nov 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as “LOX-1”), and pharmaceutical compositions and methods of treatment comprising the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.